Phase I study of high-dose dimethylbusulfan followed by autologous bone marrow transplantation in patients with advanced malignancy

Cancer Treat Rep. 1987 Jan;71(1):101-2.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Bone Marrow Transplantation*
  • Busulfan / administration & dosage
  • Busulfan / adverse effects
  • Busulfan / analogs & derivatives*
  • Child
  • Combined Modality Therapy
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasms / drug therapy*

Substances

  • dimethylmyleran
  • Busulfan